Induction of AD using ICV-STZ injection resulted in significant cognitive impairment, oxidative stress, defective Aβ clearance, and histopathological abnormalities that may be attributable to the upsurged TGF-β1/p-Smad2/p21 signaling. The gene discussed is TGFB1; the disease is Alzheimer disease.